Mernova Medicinal

Creso delivers second consecutive quarter of record revenue growth

Finfeed Archived Jul 01, 2021

Creso Pharma (ASX: CPH) has achieved strong sales growth for the June quarter generating a total of A$1,715,933 - a 24% increase on the previous quarter (Q1 CY2021: A$1,385,000).

Creso Pharma’s Mernova receives esteemed award

Finfeed Archived May 17, 2021

Creso Pharma's (ASX: CPH) Mernova Medicinal Inc. has been awarded Craft Designation by the Ontario Cannabis Store (OTC).

Pre-roll joint market provides multiple growth opportunities for Creso

Finfeed Archived Apr 08, 2021

Creso Pharma's (ASX: CPH) wholly-owned Canadian subsidiary, Mernova Medicinal has secured new purchase orders valued at C$145,192